A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation. Estudio multicentrico, aleatorizado, en doble ciego, controlado con placebo y de grupos paralelos, de MOA-728 subcutanea para el tratamiento del estrenimiento inducido por opiaceos
Latest Information Update: 01 May 2012
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 01 May 2012 Actual end date 1 Jun 2009 added as reported by European Clinical Trials Database.
- 28 Apr 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 13 Jul 2011 New trial record